- Home
- RCG vs CLDI Comparison
RCG vs CLDI Comparison
Compare RCG & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCG
- CLDI
- Stock Information
- Founded
- RCG 1994
- CLDI 2014
- Country
- RCG United States
- CLDI United States
- Employees
- RCG N/A
- CLDI N/A
- Industry
- RCG Investment Managers
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCG Finance
- CLDI Health Care
- Exchange
- RCG Nasdaq
- CLDI Nasdaq
- Market Cap
- RCG 18.2M
- CLDI 20.2M
- IPO Year
- RCG N/A
- CLDI N/A
- Fundamental
- Price
- RCG $2.66
- CLDI $5.30
- Analyst Decision
- RCG
- CLDI
- Analyst Count
- RCG 0
- CLDI 0
- Target Price
- RCG N/A
- CLDI N/A
- AVG Volume (30 Days)
- RCG 5.9K
- CLDI 961.1K
- Earning Date
- RCG 01-01-0001
- CLDI 08-08-2025
- Dividend Yield
- RCG 0.98%
- CLDI N/A
- EPS Growth
- RCG N/A
- CLDI N/A
- EPS
- RCG N/A
- CLDI N/A
- Revenue
- RCG N/A
- CLDI N/A
- Revenue This Year
- RCG N/A
- CLDI N/A
- Revenue Next Year
- RCG N/A
- CLDI N/A
- P/E Ratio
- RCG N/A
- CLDI N/A
- Revenue Growth
- RCG N/A
- CLDI N/A
- 52 Week Low
- RCG $1.52
- CLDI $2.43
- 52 Week High
- RCG $1.90
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- RCG 54.51
- CLDI 44.17
- Support Level
- RCG $2.55
- CLDI $4.85
- Resistance Level
- RCG $2.62
- CLDI $6.06
- Average True Range (ATR)
- RCG 0.08
- CLDI 1.03
- MACD
- RCG 0.00
- CLDI -0.31
- Stochastic Oscillator
- RCG 80.00
- CLDI 8.91
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.